Open research seminar with speakers Michael Rogers and Bruce Zetter from Boston Children’s Hospital and Harvard Medical School. Michael Rogers’ talk: “Validation of Anthrax Toxin Receptor 2 (Antxr2/CMG2) as a Target for Small Molecule Antiangiogenic Therapy.” Bruce Zetter’s talk: “Drug discovery for treating metastatic cancers.”

Welcome to an open research seminar, hosted by CCBIO as part of the CCBIO/Harvard INTPART partnership, in the CCBIO Seminar series as a CCBIO Special Seminar.

The seminar is part of a 3 week course in Cancer-Related Vascular Biology, but as an open research seminar for those who would like to attend the lectures by our Harvard colleagues, but do not wish to follow the entire course. It is open for all, no registration, and no charge.

First speaker is Assistant Professor Michael Rogers from the Vascular Biology Program, Boston Children’s Hospital and Harvard Medical School.

Title: “Validation of Anthrax Toxin Receptor 2 (Antxr2/CMG2) as a Target for Small Molecule Antiangiogenic Therapy.”

Second speaker is Professor Bruce Zetter, Boston Children’s Hospital, and Charles Nowiszewski Professor of Cancer Biology, Surgery, Harvard Medical School.

Title: “Drug discovery for treating metastatic cancers.”

When: Thursday September 20th 09:00-12:00:

09:00-10:00 Michael Rogers

10:00-11:00 Coffee and discussion

11:00-12:00 Bruce Zetter

Where: Auditorium 4, BB-building, at Haukeland University Hospital campus.

You are all welcome!